138 related articles for article (PubMed ID: 12112216)
1. Paradoxical response to apomorphine in a case of atypical parkinsonism.
Cicarelli G; Pellecchia MT; De Michele G; Pizzolato G; Barone P
Mov Disord; 2002 May; 17(3):604-6. PubMed ID: 12112216
[TBL] [Abstract][Full Text] [Related]
2. [Apomorphine test: evaluation of dopaminergic response in patients with Parkinson disease].
Miranda M; Saéz D
Rev Med Chil; 1995 Mar; 123(3):326-9. PubMed ID: 8525172
[TBL] [Abstract][Full Text] [Related]
3. Dopa-responsive parkinsonism phenotype of spinocerebellar ataxia type 2.
Lu CS; Wu Chou YH; Yen TC; Tsai CH; Chen RS; Chang HC
Mov Disord; 2002 Sep; 17(5):1046-51. PubMed ID: 12360557
[TBL] [Abstract][Full Text] [Related]
4. Levodopa treatment does not affect low-dose apomorphine test in patients with Parkinson's disease.
Happe S; Tings T; Helmschmied K; Neubert K; Wuttke W; Paulus W; Trenkwalder C
Mov Disord; 2004 Dec; 19(12):1511-5. PubMed ID: 15390061
[TBL] [Abstract][Full Text] [Related]
5. Hemiparkinsonism with a discrete lacunar infarction in the contralateral substantia nigra.
Ohta K; Obara K
Mov Disord; 2006 Jan; 21(1):124-5. PubMed ID: 16229001
[No Abstract] [Full Text] [Related]
6. Dopaminergic response in Parkinsonian phenotype of Machado-Joseph disease.
Buhmann C; Bussopulos A; Oechsner M
Mov Disord; 2003 Feb; 18(2):219-21. PubMed ID: 12539220
[TBL] [Abstract][Full Text] [Related]
7. Parkinsonism with multiple cysts in the bilateral striata.
Norimoto K; Kiuchi K; Morikawa M; Inoue Y; Kosaka J; Inoue M; Kishimoto T
Psychogeriatrics; 2011 Sep; 11(3):166-70. PubMed ID: 21951957
[TBL] [Abstract][Full Text] [Related]
8. Arg(184)His mutant GTP cyclohydrolase I, causing recessive hyperphenylalaninemia, is responsible for dopa-responsive dystonia with parkinsonism: a case report.
Kikuchi A; Takeda A; Fujihara K; Kimpara T; Shiga Y; Tanji H; Nagai M; Ichinose H; Urano F; Okamura N; Arai H; Itoyama Y
Mov Disord; 2004 May; 19(5):590-3. PubMed ID: 15133828
[TBL] [Abstract][Full Text] [Related]
9. [Differential diagnosis of atypical Parkinsonian syndromes].
Csóti I; Fornádi F
Ideggyogy Sz; 2010 Mar; 63(3-4):77-86. PubMed ID: 20405664
[TBL] [Abstract][Full Text] [Related]
10. [Atypical Parkinsonian syndromes, a challenging group of diseases].
Liimatainen S; Haapasalo H; Kähärä V; Paetau A; Honkaniemi J
Duodecim; 2005; 121(16):1757-66. PubMed ID: 16268222
[No Abstract] [Full Text] [Related]
11. Use of apomorphine in Parkinson's disease.
Stocchi F
Neurol Sci; 2008 Dec; 29 Suppl 5():S383-6. PubMed ID: 19381769
[TBL] [Abstract][Full Text] [Related]
12. [Levodopa-responsive parkinsonism-dystonia due to a traumatic injury of the substantia nigra].
Pérez Errazquin F; Gomez Heredia MJ
Neurologia; 2012 Apr; 27(3):181-3. PubMed ID: 21570743
[No Abstract] [Full Text] [Related]
13. Profile of families with parkinsonism-predominant spinocerebellar ataxia type 2 (SCA2).
Furtado S; Payami H; Lockhart PJ; Hanson M; Nutt JG; Singleton AA; Singleton A; Bower J; Utti RJ; Bird TD; de la Fuente-Fernandez R; Tsuboi Y; Klimek ML; Suchowersky O; Hardy J; Calne DB; Wszolek ZK; Farrer M; Gwinn-Hardy K; Stoessl AJ
Mov Disord; 2004 Jun; 19(6):622-9. PubMed ID: 15197699
[TBL] [Abstract][Full Text] [Related]
14. [Treatment of Parkinsonism: collaboration between the physician and the neurologist].
Vingerhoets F
Rev Med Suisse Romande; 2000 Sep; 120(9):709-16. PubMed ID: 11094535
[No Abstract] [Full Text] [Related]
15. [Dopaminergic treatment and parkinsonian syndromes].
Ghawche F; Durif F
Rev Neurol (Paris); 2003 May; 159(5 Pt 2):3S83-6. PubMed ID: 12773892
[TBL] [Abstract][Full Text] [Related]
16. SCA2 may present as levodopa-responsive parkinsonism.
Payami H; Nutt J; Gancher S; Bird T; McNeal MG; Seltzer WK; Hussey J; Lockhart P; Gwinn-Hardy K; Singleton AA; Singleton AB; Hardy J; Farrer M
Mov Disord; 2003 Apr; 18(4):425-9. PubMed ID: 12671950
[TBL] [Abstract][Full Text] [Related]
17. Parkinson's disease. Diagnosis and the initiation of therapy.
Bhat V; Weiner WJ
Minerva Med; 2005 Jun; 96(3):145-54. PubMed ID: 16175158
[TBL] [Abstract][Full Text] [Related]
18. HIV-associated Parkinsonism with levodopa-induced dyskinesia and response to highly-active antiretroviral therapy.
Kobylecki C; Silverdale MA; Varma A; Dick JP; Kellett MW
Mov Disord; 2009 Dec; 24(16):2441-2. PubMed ID: 19908326
[No Abstract] [Full Text] [Related]
19. The diagnosis of manganese-induced parkinsonism.
Cersosimo MG; Koller WC
Neurotoxicology; 2006 May; 27(3):340-6. PubMed ID: 16325915
[TBL] [Abstract][Full Text] [Related]
20. Levodopa responsiveness in disorders with parkinsonism: a review of the literature.
Constantinescu R; Richard I; Kurlan R
Mov Disord; 2007 Nov; 22(15):2141-8; quiz 2295. PubMed ID: 17534959
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
